Latest Breaking News On - Advanced prostate cancer - Page 5 : comparemela.com

Blue Earth Diagnostics Highlights Upcoming Presentation of Additional Results from Investigational Phase 3 LIGHTHOUSE Study

Results of the Investigational Phase 3 LIGHTHOUSE Study of 18F-rhPSMA-7.3 in newly diagnosed prostate cancer to be presented at 2023 ASCO Genitourinary Cancers Symposium (ASCO GU)

United statesSan franciscoScintomics gmbBrianf chapinUniversity of texas md anderson cancer centerStudy groupDivision of surgeryTechnical university of munichDuke university medical centerDepartment of urologyBlue earth diagnostic medical affairsBlue earth diagnosticsCancers symposiumProstate specific membrane antigen targetedEmission tomographyAdvanced prostate cancer

THE PROSTATE CANCER FOUNDATION ANNOUNCES 2022 CHALLENGE AWARDS TOTALING MORE THAN $12 MILLION FOR PROSTATE CANCER RESEARCH

/PRNewswire/ The Prostate Cancer Foundation (PCF) today announced the 2022 Class of PCF Team Challenge Award recipients and a total of more than $12 million.

United kingdomUnited statesDana farber cancer instituteSan diegoLos angelesSan franciscoSangeeta goswamiLorelei mucciBrent roseDavid quigleyDominic smiragliaHoward scherChristina dieli conwrightNigel monganDaniel georgeStacil vernick

Veru Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

Veru Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMitchell steinerSamuel fischexecutiveHannah gendelmanagerEli lillyEmergency taskVeru incSexual health program highlightsProstate cancer program highlights sabizabulinAdvisory committeeBreast cancer program highlights enobosarmVeru inc condensed consolidated balance sheetsAustralia therapeutic goods administrationEmergency task forceAllergy drugs advisory committee

Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat

Clovis Oncology, Inc. today announced the presentation of data from the TRITON3 Phase 3 trial in men with metastatic castration-resistant prostate cancer with BRCA or ATM mutations. The presentation. | October 27, 2022

United statesAlanh brycePatrickj mahaffyClovis oncology incNational cancer instituteExchange commissionProstate cancer foundationAmerican cancer societyClinical cancer researchDivision of hematologyClovis oncologyHomologous recombination deficiencyMedical oncologyMayo clinicClinical trialAnnual prostate cancer foundation

Chester Ironman grandad Jim pleased to join prostate cancer research trial

A GRANDAD from Chester is helping global research into the treatment and care of men with prostate cancer.

United statesUnited kingdomAzman ibrahimJenny leeIsabel syndikusKay mcdonaldKathryn hughesClatterbridge cancer centreMovember foundationInternational registry for menClatterbridge cancerUrology awareness monthInternational registryAdvanced prostate cancerIronmant shirtClatterbridge consultant oncologist dr azman